These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 33199780)

  • 1. AdipoR1/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis.
    Xu H; Zhao Q; Song N; Yan Z; Lin R; Wu S; Jiang L; Hong S; Xie J; Zhou H; Wang R; Jiang X
    Nat Commun; 2020 Nov; 11(1):5807. PubMed ID: 33199780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
    Cai CX; Buddha H; Castelino-Prabhu S; Zhang Z; Britton RS; Bacon BR; Neuschwander-Tetri BA
    Dig Dis Sci; 2017 Apr; 62(4):968-978. PubMed ID: 28194671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of AdipoR1 and AdipoR2 in liver fibrosis.
    Alzahrani B; Iseli T; Ramezani-Moghadam M; Ho V; Wankell M; Sun EJ; Qiao L; George J; Hebbard LW
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):700-708. PubMed ID: 29237572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice.
    Takatani N; Kono Y; Beppu F; Okamatsu-Ogura Y; Yamano Y; Miyashita K; Hosokawa M
    Biochem Biophys Res Commun; 2020 Jul; 528(2):305-310. PubMed ID: 32475638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.
    Okada-Iwabu M; Yamauchi T; Iwabu M; Honma T; Hamagami K; Matsuda K; Yamaguchi M; Tanabe H; Kimura-Someya T; Shirouzu M; Ogata H; Tokuyama K; Ueki K; Nagano T; Tanaka A; Yokoyama S; Kadowaki T
    Nature; 2013 Nov; 503(7477):493-9. PubMed ID: 24172895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin homolog novel osmotin protects obesity/diabetes-induced NAFLD by upregulating AdipoRs/PPARα signaling in ob/ob and db/db transgenic mouse models.
    Ahmad A; Ali T; Kim MW; Khan A; Jo MH; Rehman SU; Khan MS; Abid NB; Khan M; Ullah R; Jo MG; Kim MO
    Metabolism; 2019 Jan; 90():31-43. PubMed ID: 30473057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Danthron ameliorates obesity and MAFLD through activating the interplay between PPARα/RXRα heterodimer and adiponectin receptor 2.
    Ma C; Wang Z; Xia R; Wei L; Zhang C; Zhang J; Zhao L; Wu H; Kang L; Yang S
    Biomed Pharmacother; 2021 May; 137():111344. PubMed ID: 33581653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice.
    Tomita K; Oike Y; Teratani T; Taguchi T; Noguchi M; Suzuki T; Mizutani A; Yokoyama H; Irie R; Sumimoto H; Takayanagi A; Miyashita K; Akao M; Tabata M; Tamiya G; Ohkura T; Hibi T
    Hepatology; 2008 Aug; 48(2):458-73. PubMed ID: 18666257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver X Receptor Inverse Agonist SR9243 Suppresses Nonalcoholic Steatohepatitis Intrahepatic Inflammation and Fibrosis.
    Huang P; Kaluba B; Jiang XL; Chang S; Tang XF; Mao LF; Zhang ZP; Huang FZ
    Biomed Res Int; 2018; 2018():8071093. PubMed ID: 29670908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wogonin mitigates nonalcoholic fatty liver disease via enhancing PPARα/AdipoR2, in vivo and in vitro.
    Chen J; Liu J; Wang Y; Hu X; Zhou F; Hu Y; Yuan Y; Xu Y
    Biomed Pharmacother; 2017 Jul; 91():621-631. PubMed ID: 28486193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease.
    Kumar DP; Caffrey R; Marioneaux J; Santhekadur PK; Bhat M; Alonso C; Koduru SV; Philip B; Jain MR; Giri SR; Bedossa P; Sanyal AJ
    Sci Rep; 2020 Jun; 10(1):9330. PubMed ID: 32518275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEG-BHD1028 Peptide Regulates Insulin Resistance and Fatty Acid β-Oxidation, and Mitochondrial Biogenesis by Binding to Two Heterogeneous Binding Sites of Adiponectin Receptors, AdipoR1 and AdipoR2.
    Lee IK; Kim G; Kim DH; Kim BB
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice.
    Kim KH; Kim SH; Han DH; Jo YS; Lee YH; Lee MS
    Sci Rep; 2018 May; 8(1):6789. PubMed ID: 29717162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydronidone induces apoptosis in activated hepatic stellate cells through endoplasmic reticulum stress-associated mitochondrial apoptotic pathway.
    Sun Z; Guo Y; Xu X; Zhou C; Luo X; Shen Z; Shen B; Wang J; Lu J; Zhang Q; Shen F; Yu L; Ye Y; Zhang L; Luo Y; Qu Y; Cai X; Dong H; Lu L
    J Gastroenterol Hepatol; 2024 Aug; 39(8):1695-1703. PubMed ID: 38804845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of SREBP-1c ameliorates iron-induced liver fibrosis by decreasing lipocalin-2.
    Lee EH; Lee JH; Kim DY; Lee YS; Jo Y; Dao T; Kim KE; Song DK; Seo JH; Seo YK; Seong JK; Moon C; Han E; Kim MK; Ryu S; Shin M; Roh GS; Jung HR; Osborne TF; Ryu D; Jeon TI; Im SS
    Exp Mol Med; 2024 Apr; 56(4):1001-1012. PubMed ID: 38622198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models.
    Jain MR; Giri SR; Bhoi B; Trivedi C; Rath A; Rathod R; Ranvir R; Kadam S; Patel H; Swain P; Roy SS; Das N; Karmakar E; Wahli W; Patel PR
    Liver Int; 2018 Jun; 38(6):1084-1094. PubMed ID: 29164820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis.
    Fujinaga Y; Kawaratani H; Kaya D; Tsuji Y; Ozutsumi T; Furukawa M; Kitagawa K; Sato S; Nishimura N; Sawada Y; Takaya H; Kaji K; Shimozato N; Moriya K; Namisaki T; Akahane T; Mitoro A; Yoshiji H
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32759852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis.
    Akbari R; Behdarvand T; Afarin R; Yaghooti H; Jalali MT; Mohammadtaghvaei N
    BMC Pharmacol Toxicol; 2021 Oct; 22(1):53. PubMed ID: 34593018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin decreases myocardial adiponectin receptor 1 expression via PI3K/Akt and FoxO1 pathway.
    Cui XB; Wang C; Li L; Fan D; Zhou Y; Wu D; Cui QH; Fu FY; Wu LL
    Cardiovasc Res; 2012 Jan; 93(1):69-78. PubMed ID: 22012952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI3-kinase/Akt pathway-regulated membrane transportation of acid-sensing ion channel 1a/Calcium ion influx/endoplasmic reticulum stress activation on PDGF-induced HSC Activation.
    Zuo L; Zhu Y; Hu L; Liu Y; Wang Y; Hu Y; Wang H; Pan X; Li K; Du N; Huang Y
    J Cell Mol Med; 2019 Jun; 23(6):3940-3950. PubMed ID: 30938088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.